CURRENT PROJECTS OF I-COMET TEAM MEMBERS
In 2022 I-COMET was granted from NCN for more than 2 mln PLN including: Pharmacogenomics of SGLT2 inhibitors – investigating the role of empagliflozin in epigenetic… Read More »CURRENT PROJECTS OF I-COMET TEAM MEMBERS